Table 1.
Characteristics of the study groups.
| Group | Gender | Age (in years) | Ø Age ± SD | DS | PMI (h) | Ø PMI (h) ± SD | Tissue Weight (g) |
PD Braak/ AD Braak |
CDR | CERAD |
|---|---|---|---|---|---|---|---|---|---|---|
| Control | Female | 88 | 78.8 ± 6.9 | NA | ~13:00 | 14:04 ± 0.13 | 0.2306 | NA | NA | NA |
| Male | 80 | NA | 19:39 | 0.4616 | NA | NA | NA | |||
| Female | 73 | NA | 13:30 | 0.4076 | NA | NA | NA | |||
| Male | 82 | NA | 12:11 | 0.2530 | NA | NA | NA | |||
| Female | 71 | NA | 12:00 | 0.3925 | NA | NA | NA | |||
| PD | Female | 87 | 80.8 ± 6.8 | 3 | 13:08 | 14:19 ± 0.12 | 0.2461 | 3/3 | 0 | none |
| Male | 88 | 5 | 11:20 | 0.3607 | 5/3 | 0.5 | moderate | |||
| Female | 75 | 3 | 14:40 | 0.6556 | 3/2 | 0 | moderate | |||
| Male | 81 | 6 | 19:10 | 1.1524 | 6/2 | 3 | moderate | |||
| Female | 73 | 3 | 13:20 | 0.4838 | 3/2 | 0 | none |
AD: Alzheimer’s disease; Ø Age ± SD: average age and standard deviation; DS: disease stage according to neuropathological classification (Braak scale); PMI: postmortem interval; Ø PMI ± SD: average PMI and standard deviation; NA: not applicable, CDR: clinical dementia rating, CERAD: Consortium to Establish a Registry for Alzheimer’s Disease.